Improvements in Eliciting Dose Across Baseline Sensitivities Following 12 Months of Epicutaneous Immunotherapy (EPIT) in Peanut-Allergic Children Aged 4 to 11 Years

Publication date: Available online 2 June 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Matthew Greenhawt, Edwin H. Kim, Dianne E. Campbell, Todd D. Green, Romain Lambert, David M. Fleischer
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research